For health, 
with humanity

We are a world-leading company 100% focussed on everyday health. Our leading brands are built on science, innovation and human understanding and are trusted by millions of consumers globally. Our purpose is to deliver better everyday health with humanity.

Download the Haleon factsheet to learn more.

Factsheet

Investment case

  • Haleon is a global leader in the c. £200bn1 Consumer Healthcare market which is underpinned by long term structural tailwinds and resilient categories
  • We have a portfolio of Superior Brands which are rooted in Trusted Science which outperform through our leading route to market capabilities
  • See significant headroom for growth in addressing incidence vs treatment penetration, innovation led premiumisation and expanding reach to low-income consumers
  • As a standalone company, we are driving a step change in our supply chain which will drive £800m in gross cost savings over the next five years
  • Compelling financial algorithm of 4-6% annual organic revenue growth2 and high-single digit adj. operating profit growth2 at constant currency enabling strong EPS3 growth
  • Strong free cash2 generation allowing disciplined capital allocation resulting in industry leading shareholder returns

Fireside with Tobias Hestler and Dawn Allen  

Dawn Allen assumed her role as Chief Financial Officer and Board member of Haleon in November 2024.  

Dawn joined us from Tate & Lyle plc where she was CFO and member of the Executive Team and Board. Prior to this, Dawn spent 25 years at Mars Inc. where she was more recently Global CFO and Vice President of Global Transformation.

Behind the Brands with Investor Relations

While Haleon may be a relatively new name, many of our brands have been loved and trusted for generations. Join the Investor Relations team as we deep dive into some of these brands; showcasing their history and innovation. 

Tums: Looking closer at the brand’s history, innovation, and marketing, which combined with efficacy addresses a real health need of heartburn, making it America’s number one antacid. 

Panadol: A trusted global brand powered by science and deep human understanding. For generations, Panadol has been providing relief and care, making it a staple in homes around the world.

Updates

For the most up to date information on financial performance, shareholder services and more information.

Regulatory news

Annual Report 2024

Haleon has a strong portfolio of brands and is well positioned to play a vital role for people all around the world, in a sector that is growing and more relevant than ever.

You may also be interested in

Our Impact

We aim to make better everyday health more achievable, inclusive and sustainable.

 

Read More

Shareholder information

Learn more about managing your shares, our AGM and find FAQs.

 

Read More

Debt investors

Learn more about how we manage funding requirements and financial risks in support of our strategic objectives.

Read More

Contact information

If you are an institutional shareholder or equity analyst and would like information on Haleon, please contact our investor relations team.

Investor Relations contacts

1 Nicholas Hall (VMS,OTC) and Global Data (Oral Health) 2024
2 See FY 2024 Annual Report for definitions
3 Refers to adjusted EPS; see FY 2024 Annual Report for definitions